Investing
Walgreen must face US lawsuit alleging false claims over hepatitis C drugs
© Reuters. FILE PHOTO: Pigeons are seen resting on signage for Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly/File Photo
(Reuters) – A federal appeals court on Tuesday revived a lawsuit by the United States and Virginia that accused Walgreens Boots Alliance (NASDAQ:) of misrepresenting that some patients met Virginia’s Medicaid-eligibility requirements for expensive hepatitis C drugs.
The 4th U.S. Circuit Court of Appeals said the governments plausibly alleged that Walgreen’s misrepresentations were material, and vacated a lower court ruling to the contrary.
Walgreen’s had been accused of violating the federal False Claims Act and Virginia state law.
Read the full article here
-
Investing5 days ago
Hurricane Helene Hits Spruce Pine Mine, Quartz Used for Tech
-
Side Hustles6 days ago
5 Key Strategies for a Seamless Cloud Migration
-
Investing7 days ago
Israel stocks lower at close of trade; TA 35 down 0.23% By Investing.com
-
Side Hustles6 days ago
Why the Future of Cybersecurity Marketing Relies on Trust
-
Side Hustles5 days ago
VP Exec’s Top Tips for Negotiating and Relationship-Building
-
Passive Income6 days ago
Go Paperless with the PDF Reader Pro for $49.99
-
Side Hustles5 days ago
Why the Smallest Details Mean the Most in Marketing
-
Make Money5 days ago
The Top Employers and Opportunities for Part-Time Remote Jobs